Status:
COMPLETED
Duragen® Secure Post Marketing Clinical Follow-up (PMCF)
Lead Sponsor:
Integra LifeSciences Corporation
Conditions:
Dura Mater Nick Cut or Tear
Surgery
Eligibility:
All Genders
Brief Summary
The purpose of this study is to gather information about post-market performance of DuraGen Secure.The aim of this post market clinical follow-up (PMCF) is to obtain post market clinical data to evalu...
Eligibility Criteria
Inclusion
- Patient who have undergone a neurosurgical procedure where DuraGen® Secure has been implanted
Exclusion
- Patient who does not agree to allow collection of his/her medical data
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02225080
Start Date
October 1 2014
End Date
June 1 2016
Last Update
October 9 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Lariboisière
Paris, France
2
die Charité - Universitätsmedizin Berlin
Berlin, Germany
3
Hospital Universitario 12 de Octubre
Madrid, Spain
4
Hospital Universitario La Fe
Valencia, Spain